Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants
Completed · Phase 3
Conditions studied: Kidney Transplant Rejection
In brief
The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune tolerance in recipients of human leukocyte antigen (HLA)-matched, living donor kidney transplants.
Key facts
- Study ID
- NCT03363945
- Run by
- Medeor Therapeutics, Inc.
- People needed
- 30
- Starts
- 2018-03-15
- Expected to finish
- 2024-04-11
- Last updated by the study team
- 2024-06-07
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Loma Linda University Medical Center — Loma Linda, California, United States
- USC — Los Angeles, California, United States
- Stanford University Medical Center — Stanford, California, United States
- University of Colorado Denver — Aurora, Colorado, United States
- Yale University — New Haven, Connecticut, United States
- Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Mayo Clinic Hospital — Jacksonville, Florida, United States
- Loyola University Medical Center — Maywood, Illinois, United States
- Mayo Clinic — Rochester, Minnesota, United States
- RWJBarnabas Health — Orange, New Jersey, United States
- Upstate University Hospital — Syracuse, New York, United States
- University Hospitals Cleveland Medical Center — Cleveland, Ohio, United States
- Thomas Jefferson University — Philadelphia, Pennsylvania, United States
- Baylor University Medical Center — Dallas, Texas, United States
- The Methodist Hospital — Houston, Texas, United States
- Intermountain Transplant Center — Murray, Utah, United States
- INOVA Fairfax Hospital — Fairfax, Virginia, United States
- University of Wisconsin School of Medicine — Madison, Wisconsin, United States
- CIUSSS de l'Est- de-l'Île-de-Montréal Installation Hopital Maisonneuve-Rosemont — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.